US Judge Rules Against FDA on Premium Cigar Regulation

Jul.07.2022
US Judge Rules Against FDA on Premium Cigar Regulation
A US judge ruled FDA's decision on regulating premium cigars as arbitrary and capricious, asks for briefing on decision reversal.

On Tuesday, a federal judge in the U.S. ruled that the FDA's decision to regulate premium cigars under the same federal laws as cigarettes and other tobacco products was arbitrary and capricious.


District Judge Amit Mehta in Washington D.C. has stated that the FDA disregarded relevant data on the health risks associated with high-quality cigars. He has requested the FDA and industry groups that question this regulation, including the Premium Cigar Association and the Cigar Rights of America, to submit briefs explaining why he should overturn the FDA's decision.


Michael Edney, the attorney for the plaintiff firm Steptoe & Johnson, stated that the family-owned manufacturer and retailer of high-quality cigars has long believed that the FDA has mishandled its regulation of premium cigars. He expressed gratitude for the court's ruling and the opportunity to pursue further legal action on this matter.


At this time, it is not possible to immediately reach out to the FDA for comment on this matter.


The focus of the lawsuit is the so-called certification rules passed by the agency in 2016, in which it exercised regulatory authority over a wide range of tobacco products, including premium cigars and cigarettes, under the Family Smoking Prevention and Tobacco Control Act.


The plaintiff stated that the organization considered and rejected high-quality cigars before finalizing its regulations, as well as during additional consultations in 2017 and 2018.


According to them, the FDA's regulations require cigar manufacturers to register their products annually and provide a list of ingredients for each product. They also require all products to undergo laboratory testing, which is impractical for "craftsmen" who produce high-quality handmade cigars.


Industry organizations state that unlike cigarettes and e-cigarettes, high-quality cigars are not appealing to young people and are not associated with addiction. They cite research indicating that young people are unlikely to use high-quality cigars, and those who do use them are unlikely to smoke cigars on a regular basis, thus not contributing to increased death rates.


On Monday, Mehta agreed that the FDA did not adequately consider the studies cited by the plaintiffs and instead claimed "there is no evidence to suggest" that high-quality cigars pose less of a health risk.


The judge wrote that when an institution unequivocally claims there is no evidence, while in fact there are relevant documented pieces of evidence, and the institution ignores or disregards it, it acts arbitrarily and capriciously.


The case is the lawsuit filed by the U.S. Cigar Association against the FDA in the District Court of Columbia, case number 16-cv-01460.


This article is a compilation of information from third-party sources and is intended solely for educational and informational purposes. All copyrights to the compiled information belong to the original media and authors, and any infringements should be reported for prompt removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Itsuwa Posts 194% Drop in 2024 Net Profit with $2.7M Loss, to Focus on Modular and Eco-Friendly E-Cigarettes
Itsuwa Posts 194% Drop in 2024 Net Profit with $2.7M Loss, to Focus on Modular and Eco-Friendly E-Cigarettes
Itsuwa Technology (NEEQ: 833767) released its 2024 annual report, reporting revenue of 283 million yuan, down 12.59% year-on-year, and a net loss of 19.66 million yuan, a 194.47% decline from the previous year. The company attributed the loss to intense competition and product homogeneity in overseas markets, as well as rising labor costs. Its gross profit margin dropped to 30%, while R&D spending accounted for 9.12% of revenue. Going forward, the company plans to focus on developing eco-friendl
May.13 by 2FIRSTS.ai
Ispire Clarifies: Malaysia Plant Does Not Involve Nicotine or Cannabis Products, All Production for Export Only
Ispire Clarifies: Malaysia Plant Does Not Involve Nicotine or Cannabis Products, All Production for Export Only
Ispire stated that its Malaysia facility complies with local laws and only produces semi-finished vaporizer hardware without nicotine or cannabis. All products are for export and not distributed or sold in the local market.
Jun.10 by 2FIRSTS.ai
2Firsts’ CEO Analyzes the 2024 World Tobacco Development Report from Five Key Perspectives
2Firsts’ CEO Analyzes the 2024 World Tobacco Development Report from Five Key Perspectives
China Tobacco's authoritative report on global tobacco development in 2024 was analyzed by 2Firsts CEO Alan Zhao, shedding light on key trends.
May.29 by 2FIRSTS.ai
South Korea Report: Heated Tobacco Sales Soar 2,500-Fold Globally Over a Decade, Prompting Urgent Call for Stricter Regulations
South Korea Report: Heated Tobacco Sales Soar 2,500-Fold Globally Over a Decade, Prompting Urgent Call for Stricter Regulations
The Korea Health Promotion Institute has called for stronger regulation of e-cigarettes and other novel tobacco products, emphasizing the need to protect minors from the influence of tobacco advertising.
May.21 by 2FIRSTS.ai
Exhibition Observation | HQD and OEM Brand AVOTX Jointly Participate in the Exhibition, Focusing on Customized OEM Business
Exhibition Observation | HQD and OEM Brand AVOTX Jointly Participate in the Exhibition, Focusing on Customized OEM Business
At the 2025 Dubai World Vape Show, HQD and its OEM technology brand AVOTX jointly participated in the exhibition with a unified booth design style. AVOTX showcased a variety of OEM products, including e-cigarettes with transparent oil tanks and metal materials.
Jun.23
Malaysian Ministry of Health Forms Special Committee to Tackle Student Vaping Abuse
Malaysian Ministry of Health Forms Special Committee to Tackle Student Vaping Abuse
The Malaysian Ministry of Health has established a special committee to investigate the misuse of e-cigarettes among students and to evaluate the implementation of the Public Health (Control of Smoking Products) Act 2024. The minister emphasized that regulations will be driven by evidence.
May.14 by 2FIRSTS.ai